GTG genetic technologies limited

0.00%

3.9¢

Splice11, great response, goodd overview thanks for enlightening...

First 4 Last

Share
Profile

Follow
KenChase

1,096 Posts.

378

13/06/19

14:18

Post #: 39041854
Share

Originally posted by splice11: ↑

here are some observations, some are subjective some not so much:

- Brevagen didn't succeed in market, brevagenPlus didnt succeed in market, Genetype for breast cancer is 6 months late and counting, no eta on when it will be released except 'in the coming months' which knowing this company can be 2020 or 2021, and they won't bother explaining why the delays, just a quiet re-forecast in each quarterly, and have the audacity to write 'remains on schedule' after delaying it 6 months. Shows how little they think of shareholder intelligence IMO.

- Also, the test might be getting better, but I don't see a definite market for it. If the test was wanted, Brevagenplus would have been a success. This might be the reason they are trying to enter Chinese market, but no statistical validation for that population (add +12 months for this and more CR / share dilution).

- Shady dumping of a director's entire holding in his own company ($700,000).

- Old board was trying to sell the company, got kicked out by the new mob during a hostile takeover under the guise of promising to align the company with blockchain tech. Gradually this has reduced to ZERO alignment - totally exiting the company vernacular (blockchain not mentioned ONCE in the latest investor presentation or 4C). Again, no explanation to shareholders why, or what's happening with Shivom, blockshine etc. All ventures presumed dead.

- Check the financials. Measly $5,000 incoming cash this quarter, but $789,000 outgoing in salaries alone!!!!!! for ONE quarter!

- CEO is "interim" since 1.5 years, company has promised to find a new CEO replacement, and this hasn't been done. Announcement on 6th Feb, 2018 "In the interim, Dr Kasian has been appointed as acting Chief Executive Office, whilst the Companyundertakes an executive search for a new chief executive officer. " Then, 10 MONTHS later, in November 2018 they announce "The Board has also recently committed to undertake an executive search for a full time CEO. " RECENTLY!?!?! Anyway, here we are, 18 months later and STILL (LOL) one person is both CEO AND Chairman, a recipe for conflict of interest imo.

- One person is COO, CFO and Company secretary.

Good time to sell, before the price tanks even more. Market cap is unbelievably inflated IMO. Soon they will reverse split and the share price will look pretty, and the dilution cycle will begin again.

As usual, all IMO/DYOR/I-could-be-wrong etc etc. Proceed with caution.

Expand

Splice11, great response, goodd overview thanks for enlightening me. Apprieciate it. Unfortunately I have to hold till I get back to the .015 mark. Was relying on Genetype for that.

GTG Price at posting: 0.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

AII

Inside the depths of Panasqueira: A legacy carved in rock

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change 0.000(0.00%)		Mkt cap ! $52.08M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Splice11, great response, goodd overview thanks for enlightening...

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Inside the depths of Panasqueira: A legacy carved in rock

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

Rare earths stocks surge as Pentagon buys big stake in US REE miner

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Featured News

Featured News

Splice11, great response, goodd overview thanks for enlightening...

Top Stories

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Inside the depths of Panasqueira: A legacy carved in rock

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Trump just dropped a 200% tariff bomb. Here's how to cash in

Rare earths stocks surge as Pentagon buys big stake in US REE miner

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Featured News

Featured News